We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+6.09%
1 Year Est. Return
+29.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11.1B
AUM Growth
+$425M
Cap. Flow
-$153M
Cap. Flow %
-1.39%
Top 10 Hldgs %
13.2%
Holding
1,037
New
126
Increased
274
Reduced
260
Closed
166

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$87.1M
2
MDT icon
Medtronic
MDT
+$63.8M
3
VYX icon
NCR Voyix
VYX
+$35.3M
4
WU icon
Western Union
WU
+$28.9M
5
HCA icon
HCA Healthcare
HCA
+$27.7M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$74.9M
2
RHP icon
Ryman Hospitality Properties
RHP
+$48.9M
3
QCOM icon
Qualcomm
QCOM
+$44.5M
4
PRXL
Parexel International Corp
PRXL
+$34.6M
5
DECK icon
Deckers Outdoor
DECK
+$30.6M

Sector Composition

Rank Sector Weight
1 Financials 17.55%
2 Healthcare 16.16%
3 Technology 14.7%
4 Consumer Discretionary 9.66%
5 Industrials 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBT
901
Permian Basin Royalty Trust
PBT
$1.38B
– –
-21,900
Closed -$191K
PKG icon
902
Packaging Corp of America
PKG
$21.9B
– –
-6,580
Closed -$755K
PLAB icon
903
Photronics
PLAB
$1.79B
– –
-60,465
Closed -$535K
REVG
904
DELISTED
REV Group
REVG
– –
-9,453
Closed -$272K
RJF icon
905
Raymond James Financial
RJF
$33.8B
– –
-3,900
Closed -$219K
RMR icon
906
The RMR Group
RMR
$325M
– –
-53,254
Closed -$2.73M
RWT
907
Redwood Trust
RWT
$574M
– –
-75,185
Closed -$1.23M
SBRA icon
908
Sabra Healthcare REIT
SBRA
$5.34B
– –
-60,976
Closed -$1.34M
SGRY icon
909
Surgery Partners
SGRY
$2.01B
– –
-20,330
Closed -$210K
HTO
910
H2O America
HTO
$2.57B
– –
-18,120
Closed -$1.03M
SLGN icon
911
Silgan Holdings
SLGN
$4.23B
– –
-81,225
Closed -$2.39M
SLM icon
912
SLM Corp
SLM
$4.89B
– –
-19,700
Closed -$226K
STLD icon
913
Steel Dynamics
STLD
$36B
– –
-27,385
Closed -$944K
TAP icon
914
Molson Coors Class B
TAP
$7.79B
– –
-4,233
Closed -$346K
TCOM icon
915
Trip.com Group
TCOM
$29.6B
– –
-35,541
Closed -$1.87M
TEVA icon
916
Teva Pharmaceuticals
TEVA
$40.8B
– –
-14,900
Closed -$263K
THC icon
917
Tenet Healthcare
THC
$20.5B
– –
-13,830
Closed -$227K
THS
918
DELISTED
Treehouse Foods
THS
– –
-2,957
Closed -$200K
TKR icon
919
Timken Company
TKR
$9.56B
– –
-18,848
Closed -$915K
TPIC
920
DELISTED
TPI Composites
TPIC
– –
-36,106
Closed -$807K
TT icon
921
Trane Technologies
TT
$100B
– –
-74,921
Closed -$6.68M
ULTA icon
922
Ulta Beauty
ULTA
$22B
– –
-10,504
Closed -$2.38M
USAC icon
923
USA Compression Partners
USAC
$3.79B
– –
-15,000
Closed -$251K
UTHR icon
924
United Therapeutics
UTHR
$25.8B
– –
-18,534
Closed -$2.17M
UTG icon
925
Reaves Utility Income Fund
UTG
$3.54B
– –
-32,200
Closed -$1.02M
35 36
37
38 39

Similar funds

TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

Sterling Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Sterling Capital Management held 1,037 positions worth $11.1B, up 4% from $10.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Sterling Capital Management's Q4 2017 filing shows 126 new, 274 increased, 260 reduced and 166 closed positions. Its largest new stake was Analog Devices: 982,934 shares worth $87.5M. The largest sale was Novartis, an estimated $74.9M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

  • Sterling Capital Management's largest Q4 2017 buy was Analog Devices: 982,934 shares worth $87.5M.
  • Sterling Capital Management added most to Medtronic in Q4 2017, an estimated $63.8M increase.
  • Sterling Capital Management's biggest Q4 2017 reduction was Novartis, cutting an estimated $74.9M.
  • Sterling Capital Management fully exited Parexel International Corp in Q4 2017, selling an estimated $34.6M.
  • Sterling Capital Management's ten largest holdings make up 13% of its $11.1B portfolio in Q4 2017.
  • Sterling Capital Management opened 126 new positions and closed 166 in Q4 2017.
  • Sterling Capital Management's portfolio value rose 4% quarter-over-quarter to $11.1B.

Based on Sterling Capital Management's 13F filing for Q4 2017, filed 15 Feb 2018.